Investigating monoclonal antibody against cytokeratin 19 tumor marker
Mohammad Amin Momeni-Moghaddam, Javad Mohammadnejad, Hossein Ghahremani, Shahnaz Khaghani, Nariman Moradi, Amin Daemi, Gülüzar Özbolat, Yusuf Döğüş, Seyyedeh Touran Hosseini · 2025
Read Investigating monoclonal antibody against cytokeratin 19 tumor marker by Mohammad Amin Momeni-Moghaddam, Javad Mohammadnejad, Hossein Ghahremani, Shahnaz Khaghani, Nariman Moradi, Amin Daemi, Gülüzar Özbolat, Yusuf Döğüş, Seyyedeh Touran Hosseini (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12860061.txt.
Description
Cytokeratin 19, a scaffold protein, appears in many cancers, so a precise antibody against it could aid diagnosis. Mohammad Momeni-Moghaddam and co-authors set out in 2025 to make such a monoclonal antibody. They injected mice with a lab-made copy of the protein, fused the best responders' spleen cells with tumor cells, and screened the hybrid cells for antibody output.
From seventy-eight reactive clones, two stable lines survived repeated single-cell cloning. Tests on cancer cell lines showed the expected bands where the protein occurs, and none in a skin cancer line known to lack it. The pair gives labs a fresh, specific tool for spotting this tumor marker.
Catalog record
| CREATOR | Mohammad Amin Momeni-Moghaddam, Javad Mohammadnejad, Hossein Ghahremani, Shahnaz Khaghani, Nariman Moradi, Amin Daemi, Gülüzar Özbolat, Yusuf Döğüş, Seyyedeh Touran Hosseini |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |